Healthspan Economy

Pillar P2

Femtech & Women's Health

Femtech and women's health: fertility, hormonal health, and women-first clinical platforms across the premium tier.

50 entities

Alpha IVF Group

Malaysia's only publicly listed fertility care company; Bursa Malaysia ACE Market IPO March 2024

Alpha IVF Group is Malaysia's leading publicly listed fertility care company, founded by Dato' Dr. Colin Lee Soon Soo who holds over 40 years of experience and is credited with over a dozen world-firsts in IVF. The group listed on the ACE Market of Bursa Malaysia in March 2024 and specializes in assisted reproductive services, preimplantation genetic testing, and sperm sorting across multiple centers in Malaysia and internationally. It has been awarded Leading Fertility Innovation and Technology of the Year in APAC for six consecutive years through 2024.

Clinic Malaysia Available on request
P2

CHA Fertility Center Seoul Station

Fertility and reproductive medicine, egg freezing

CHA Fertility Center Seoul Station is a dedicated reproductive medicine centre at CHA Seoul Station Medical Center (Jung-gu, Seoul), part of CHA Medical Group. Focused exclusively on IVF, IUI, egg freezing, PGT, and fertility preservation. Distinct entity from the existing Atlas entry cha-anti-aging-center. CHA network performs 10,000+ IVF cycles annually.

Fertility_clinic South Korea egg freezing from approx. KRW 3,500,000 per entity site
P2

Juniper

Women's weight health, GLP-1 programs, menopause and hormonal health

Juniper (founded 2020 as Eucalyptus brand) is Australia's leading online women's weight management and health platform, offering medically supervised GLP-1 receptor agonist programs and MHT (menopause hormone therapy). Acquired by Hims and Hers Health in the USD 1.15B Eucalyptus acquisition closed June 2, 2026; retains operating brand identity.

Platform Australia weight management from AUD 99/month; MHT from AUD 79/month
P2

Kin Fertility

Women's fertility and reproductive health, subscription pharmacy

Kin Fertility (founded 2019 by Chloe Leschber and Sally Norris) is an Australian DTC fertility and reproductive health platform offering subscription prenatal vitamins, at-home fertility hormone testing, telehealth consultations, and egg freezing referral. Acquired by Eucalyptus; subsequently acquired by Hims and Hers Health (USD 1.15B acquisition of Eucalyptus, June 2, 2026); retains operating brand identity.

Platform Australia prenatal vitamins from AUD 49/month; fertility test kits from AUD 129
P2

Sunfert International Fertility Centre

Malaysia's largest fertility group; 1,500-plus IVF cycles annually; MHTC Fertility Centre of the Year Asia Pacific

Sunfert International Fertility Centre is Malaysia's largest fertility group, founded in 2009 by Dr. Wong Pak Seng who holds fellowship credentials from the London Fertility Centre and is a Fellow of the Royal College of Obstetricians and Gynaecologists. The center performs over 1,500 IVF cycles annually across five centers and has been recognized as Fertility Centre of the Year in Asia Pacific by the Malaysia Healthcare Travel Council.

Clinic Malaysia Available on request
P2

Thuriah Medical Center

Premium IVF and reproductive genetics center, Oncofertility Consortium member

Thuriah Medical Center is a Riyadh-based center of excellence in reproductive medicine, infertility treatment, and preimplantation genetic diagnosis, performing over 2,500 IVF cycles annually since its founding in 2001. It is ranked as Best Medical Centre in the Middle East by the Europe Business Assembly and is a member of the Oncofertility Consortium. Services include IVF, ICSI, sperm micro-dissection, and PGD/PGS; consultants hold subspecialty training from the University of Bristol and leadership positions in the Saudi Fertility Society.

Clinic Saudi Arabia Available on request
P2

FAQ

Frequently asked questions

What does the Femtech & Women's Health pillar cover?

Femtech and women's health covers fertility, hormonal health, perimenopause and menopause care, and women-first clinical platforms operating at the premium tier. This pillar of the Healthspan Economy Atlas currently maps 50 entities across 18 markets.

How are companies in this pillar selected?

Inclusion in the Atlas is editorial, not paid. We map the premium end of the pillar: operators with a defined clinical or product offering, real market presence, and relevance to how the healthspan economy is forming. No company can pay for inclusion or placement.

Is this data free to cite?

Yes. The Atlas is free to read and cite with attribution to Healthspan Economy and a link to healthspaneconomy.com.